FDA Inspection
The American National Red CrossThe American National Red Cross – FDA Inspection, Jan 30, 2017
Record Details
This FDA Inspection record concerns The American National Red Cross, with an inspection on January 30, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · de6bc49e-7012-4664-a7d6-d73eb1609816
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1001329
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of The American National Red Cross
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 9, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 27, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 18, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 15, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 25, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for The American National Red Cross
- FDA Inspection 1230695 - 2024-02-09
- FDA Inspection 1096443 - 2019-06-27
- FDA Inspection 942712 - 2015-09-18
- FDA Inspection 891408 - 2014-08-15
- FDA Inspection 837682 - 2013-06-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.